Lena Lößlein

7PUBLICATIONS
36CO-AUTHORS
Major global burdens of diseaseNeurology and neuromuscular diseasesCentral nervous systemCellular nervous systemPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 05, 2025
Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease Activity.

Thanos Tsaktanis, Leander Ammon, Lena Lößlein

|Jun 19, 2025
TGFα controls checkpoints in CNS resident and infiltrating immune cells to promote resolution of inflammation.

Lena Lößlein, Mathias Linnerbauer, Finnja Zuber

|Feb 26, 2024
The astrocyte-produced growth factor HB-EGF limits autoimmune CNS pathology.

Mathias Linnerbauer, Lena Lößlein, Oliver Vandrey

|Aug 11, 2023
Regulation of the programmed cell death protein 1/programmed cell death ligand 1 axis in relapsing-remitting multiple sclerosis.

Thanos Tsaktanis, Mathias Linnerbauer, Lena Lößlein

Pageof 2